Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
8 papers
Recent·Most cited
L. Lopez, L. G. Morosi, F. La Terza, P. Bourdely, G. Rospo, R. Amadio, G. M. Piperno, V. Russo, C. Volponi, S. Vodret, S. Joshi, F. Giannese, D. Lazarevic, G. Germano, P. Stoitzner, , F. Benvenuti
The paper shows that DC-based therapy enhances CD8 T cell responses to neoantigens in lung tumors, particularly in high TMB tumors.
bioRxiv · Jan 26, 2024 · PreprintImmunology
P. K. Kandalla, J. Subburayalu, C. Cocita, B. de Laval, E. Tomasello, J. Iacono, J. Nitsche, M. M. Canali, W. Cathou, G. Bessou, N. Mossadegh-Keller, C. Huber, S. Sarrazin, G. Mouchiroud, R. Bourette, , M. H. Sieweke
This study shows M-CSF promotes antiviral immunity against CMV after HCT by enhancing myeloid and NK cell differentiation and IL-15/IFN signaling.
EMBO Molecular Medicine · Aug 28, 2023Peer-reviewedImmunology
X. LUO, X. LAHAYE, A. JAEGER, P. MICHEA-VELOSO, N. Manel, M. DALOD
This paper develops a gene silencing pipeline to study human cDC1 and pDC development and functions, identifying key regulators and HIV-1 restriction factors.
bioRxiv · May 16, 2023 · PreprintImmunology
M. Valente, N. Collinet, T.-P. Vu Manh, K. Naciri, G. Bessou, L. Gil, P. Milpied, E. Tomasello, M. Dalod
This paper develops a pDC-reporter mouse model to unambiguously identify and compare pDC, pDC-like cells, and tDC in vivo, revealing distinct activation patterns during viral infection.
bioRxiv · Jan 7, 2022Immunology
G. Ghislat, A. S. Cheema, E. Baudoin, C. Verthuy, P. Ballester, K. Crozat, N. Attaf, C. Dong, P. Milpied, B. Malissen, N. Auphan-Anezin, T.-P. V. Manh, M. Dalod, T. Lawrence
This study identifies the NF-κB/IRF1 axis as critical for cDC1 maturation and anti-tumor immunity, showing its role in CD8+ T cell activation and tumor control.
bioRxiv · Dec 28, 2020Immunology
R. Mattiuz, C. Brousse, M. Ambrosini, J.-C. Cancel, G. Bessou, J. Mussard, A. Sanlaville, C. Caux, N. Bendriss-Vermare, J. Valladeau-Guilemond, M. Dalod, K. Crozat
This study shows that cDC1 and interferons are critical for CD4+ and CD8+ T cell responses against breast cancer, promoting infiltration and effector functions, and improving patient prognosis.
bioRxiv · Dec 23, 2020Immunology
A. Gainullina, L.-H. Huang, H. Todorov, K. Kim, L. S. Yng, A. Kent, B. Jia, K. Seddu, K. Krchma, J. Wu, K. Crozat, E. Tomasello, V. Narang, R. Dress, P. See, , ImmGen Consortium
The paper analyzes metabolic diversity in mononuclear phagocytes across tissues using integrated datasets and a network-based approach, identifying key metabolic subnetworks and their functional roles.
bioRxiv · Jul 15, 2020Immunology
S. Ghilas, M. Ambrosini, J.-C. Cancel, M. Masse, H. Lelouard, M. Dalod, K. Crozat
The paper shows NK cells guide cDC1 migration in the spleen to enhance antiviral CD8+ T cell responses during infection.
bioRxiv · Apr 23, 2020Immunology